Bon Natural Life (BON) Competitors $1.92 0.00 (0.00%) Closing price 09/26/2025 04:00 PM EasternExtended Trading$1.98 +0.06 (+2.86%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BON vs. ASLN, NMTR, SPRC, PTPI, HEPA, BPTSY, BPTH, PBLA, TRVN, and VINCShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include ASLAN Pharmaceuticals (ASLN), 9 Meters Biopharma (NMTR), SciSparc (SPRC), Petros Pharmaceuticals (PTPI), Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Bio-Path (BPTH), Panbela Therapeutics (PBLA), Trevena (TRVN), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. Its Competitors ASLAN Pharmaceuticals 9 Meters Biopharma SciSparc Petros Pharmaceuticals Hepion Pharmaceuticals Biophytis Bio-Path Panbela Therapeutics Trevena Vincerx Pharma ASLAN Pharmaceuticals (NASDAQ:ASLN) and Bon Natural Life (NYSE:BON) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability. Do insiders & institutionals hold more shares of ASLN or BON? 58.8% of ASLAN Pharmaceuticals shares are held by institutional investors. Comparatively, 0.6% of Bon Natural Life shares are held by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are held by insiders. Comparatively, 26.5% of Bon Natural Life shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, ASLN or BON? Bon Natural Life has higher revenue and earnings than ASLAN Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Bon Natural Life$23.84M0.01$400KN/AN/A Does the media favor ASLN or BON? In the previous week, ASLAN Pharmaceuticals' average media sentiment score of 0.00 equaled Bon Natural Life'saverage media sentiment score. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Bon Natural Life Neutral Which has more volatility & risk, ASLN or BON? ASLAN Pharmaceuticals has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Bon Natural Life has a beta of -0.46, meaning that its stock price is 146% less volatile than the S&P 500. Is ASLN or BON more profitable? Bon Natural Life's return on equity of 0.00% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Bon Natural Life N/A N/A N/A SummaryBon Natural Life beats ASLAN Pharmaceuticals on 5 of the 8 factors compared between the two stocks. Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeMedicinals & botanicals IndustryDiscretionary SectorNYSE ExchangeMarket Cap$321K$3.55B$8.45B$21.56BDividend YieldN/AN/A3.00%3.54%P/E RatioN/A9.6618.7529.51Price / Sales0.0183.516.1260.58Price / Cash0.785.6214.8418.12Price / Book0.051.165.014.61Net Income$400K$17.44M$258.03M$1.00B7 Day Performance-5.42%-3.38%-0.69%-0.56%1 Month Performance36.17%12.19%2.66%1.82%1 Year Performance-95.73%-19.77%46.45%12.19% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural LifeN/A$1.92flatN/A-95.7%$321K$23.84M0.00100ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A0.0020SPRCSciSparc0.3411 of 5 stars$1.81+0.3%N/A-18.5%$957K$1.31M0.004Trending NewsGap UpPTPIPetros Pharmaceuticals0.2372 of 5 stars$0.03flatN/A-99.7%$872K$5.11M-0.0120Gap DownHEPAHepion PharmaceuticalsN/A$0.06+18.0%N/A-99.8%$742KN/A-0.0120Positive NewsGap UpBPTSYBiophytisN/A$2.00flatN/AN/A$702KN/A0.0030BPTHBio-Path0.3131 of 5 stars$0.06+1.9%N/A-92.6%$498KN/A0.0010Negative NewsGap DownPBLAPanbela Therapeutics0.084 of 5 stars$0.05flatN/A-85.7%$243KN/A0.006TRVNTrevena1.5491 of 5 stars$0.25+2,400.0%$5.00+1,900.0%-99.7%$240K$443K-0.0140Gap UpVINCVincerx Pharma2.8183 of 5 stars$0.04+23.0%$40.00+88,986.9%-99.6%$235KN/A0.0060 Related Companies and Tools Related Companies ASLAN Pharmaceuticals Competitors 9 Meters Biopharma Competitors SciSparc Competitors Petros Pharmaceuticals Competitors Hepion Pharmaceuticals Competitors Biophytis Competitors Bio-Path Competitors Panbela Therapeutics Competitors Trevena Competitors Vincerx Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BON) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
